KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Shares Outstanding (Weighted Average) (2016 - 2025)

Charles River Laboratories International has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $49.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $49.6 million for Q4 2025, down 3.53% from a year ago — trailing twelve months through Dec 2025 was $49.6 million (down 3.53% YoY), and the annual figure for FY2025 was $49.6 million, down 3.53%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $49.6 million at Charles River Laboratories International, roughly flat from $49.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CRL hit a ceiling of $51.5 million in Q2 2024 and a floor of $49.6 million in Q4 2025.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $50.8 million (2022), compared with a mean of $50.7 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 1.61% in 2021 and later fell 3.53% in 2025.
  • Charles River Laboratories International's Shares Outstanding (Weighted Average) stood at $50.3 million in 2021, then grew by 1.03% to $50.8 million in 2022, then grew by 0.82% to $51.2 million in 2023, then grew by 0.3% to $51.4 million in 2024, then fell by 3.53% to $49.6 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $49.6 million (Q4 2025), $49.7 million (Q3 2025), and $49.9 million (Q2 2025) per Business Quant data.